A Multi-site Study of Autologous Cord Blood Cells for Hypoxic Ischemic Encephalopathy

NCT02612155 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Moderate or Severe Hypoxic-ischemic Encephalopathy in Newborns

Interventions

BIOLOGICAL: Infusion of autologous cord blood
BIOLOGICAL: Placebo

Sponsor

Michael Cotten

Collaborators

[object Object]